MGCD265: Additional Phase Ib data

Data from 4 evaluable non-small cell lung cancer (NSCLC) patients with c-MET or AXL gene alterations in the Phase Ib expansion cohort of the open-label, dose-escalation, international Phase I/Ib 265-1...